These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1695259)

  • 1. An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants.
    Burrows SR; Misko IS; Sculley TB; Schmidt C; Moss DJ
    J Virol; 1990 Aug; 64(8):3974-6. PubMed ID: 1695259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
    Burrows SR; Sculley TB; Misko IS; Schmidt C; Moss DJ
    J Exp Med; 1990 Jan; 171(1):345-9. PubMed ID: 1688611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3.
    Misko IS; Schmidt C; Moss DJ; Burrows SR; Sculley TB
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():405-9. PubMed ID: 1704413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
    Murray RJ; Kurilla MG; Griffin HM; Brooks JM; Mackett M; Arrand JR; Rowe M; Burrows SR; Moss DJ; Kieff E
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2906-10. PubMed ID: 2158098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation-associated Epstein-Barr virus antigens as targets for immune attack.
    Masucci MG; Gavioli R; de Campos-Lima PO; Zhang QJ; Trivedi P; Dolcetti R
    Ann N Y Acad Sci; 1993 Aug; 690():86-100. PubMed ID: 7690218
    [No Abstract]   [Full Text] [Related]  

  • 6. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    Khanna R; Burrows SR; Kurilla MG; Jacob CA; Misko IS; Sculley TB; Kieff E; Moss DJ
    J Exp Med; 1992 Jul; 176(1):169-76. PubMed ID: 1377222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
    J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
    Murray RJ; Wang D; Young LS; Wang F; Rowe M; Kieff E; Rickinson AB
    J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
    Schmidt C; Burrows SR; Sculley TB; Moss DJ; Misko IS
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9478-82. PubMed ID: 1719531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3.
    Burrows SR; Gardner J; Khanna R; Steward T; Moss DJ; Rodda S; Suhrbier A
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2489-93. PubMed ID: 7521394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligopeptide induction of a secondary cytotoxic T-cell response to Epstein-Barr virus in vitro.
    Schmidt C; Burrows SR; Moss DJ; Sculley TB; Misko IS
    Scand J Immunol; 1991 Apr; 33(4):411-20. PubMed ID: 1708166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
    Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
    Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: implications for immune therapy.
    Tao Q; Yang J; Huang H; Swinnen LJ; Ambinder RF
    Am J Pathol; 2002 May; 160(5):1839-45. PubMed ID: 12000735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population.
    Lee SP; Morgan S; Skinner J; Thomas WA; Jones SR; Sutton J; Khanna R; Whittle HC; Rickinson AB
    Eur J Immunol; 1995 Jan; 25(1):102-10. PubMed ID: 7531142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
    Brooks JM; Murray RJ; Thomas WA; Kurilla MG; Rickinson AB
    J Exp Med; 1993 Sep; 178(3):879-87. PubMed ID: 7688791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.
    Gavioli R; Kurilla MG; de Campos-Lima PO; Wallace LE; Dolcetti R; Murray RJ; Rickinson AB; Masucci MG
    J Virol; 1993 Mar; 67(3):1572-8. PubMed ID: 7679748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7.
    Hill A; Worth A; Elliott T; Rowland-Jones S; Brooks J; Rickinson A; McMichael A
    Eur J Immunol; 1995 Jan; 25(1):18-24. PubMed ID: 7531143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
    Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
    Levitsky V; Zhang QJ; Levitskaya J; Masucci MG
    J Exp Med; 1996 Mar; 183(3):915-26. PubMed ID: 8642295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis.
    Moss DJ; Misko IS; Sculley TB; Apolloni A; Khanna R; Burrows SR
    Springer Semin Immunopathol; 1991; 13(2):147-56. PubMed ID: 1724100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.